melanocortin receptor agonist
Bremelanotide clinical trials
Answer
Bremelanotide has 10 registered trials: 1 running, 9 completed, 0 stopped early. 4 posted results.
Trial registerClinicalTrials.gov, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT06867835 Trial register | Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk | completed | - | 2025-03-10 | - |
| NCT06565611 Trial register | A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity | running, but no longer enrolling | 2 | 2024-08-22 | - |
| NCT04943068 Trial register | A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Admin | completed | - | 2021-06-29 | - |
| NCT05709444 Trial register | A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease | completed | - | 2023-02-02 | - |
| NCT04179734 Trial register | Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder | completed | - | 2019-11-27 | Posted |
| NCT03973047 Trial register | Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran | completed | - | 2019-06-04 | - |
| NCT02333071 Trial register | 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder | completed | - | 2015-01-07 | Posted |
| NCT02338960 Trial register | 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder | completed | - | 2015-01-15 | Posted |
| NCT01382719 Trial register | Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder | completed | - | 2011-06-27 | Posted |
| NCT00425256 Trial register | Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) | completed | - | 2007-01-22 | - |
Source: ClinicalTrials.gov, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.